Jake Micallef PhD. MBA

Chief Scientific Officer

Jake is the Chief Scientific Officer and one of the founding scientists of Volition. He is the co-inventor and author of the patents surrounding Volition’s Nucleosomics™ technology.

Meet Jake Micallef

Jake is the Chief Scientific Officer and one of the founding scientists of Volition. He is an experienced scientist with expertise in research and development in diagnostics both commercially and for the UK National Health Service and World Health Organization. Jake is the co-inventor and author of the patents surrounding Volition’s Nucleosomics™ technology.

Jake received both his BSc in Biology and Chemistry and Ph.D. in Physical Chemistry from King’s College London. In addition, he received his MSc in Chemical Pathology from St Thomas’ Hospital Medical School and his MBA from Imperial College Management School.

“Current cancer diagnosis involves expensive, unpleasant and, often, invasive testing. Using our Nu.Q technology we aim to make cancer diagnosis as accessible as cholesterol or pregnancy testing.”

Jake Micallef

Chief Scientific Officer

Tom Butera DVM

Chief Executive Officer, Volition Veterinary Diagnostics Development LLC